The Valley Desk

NCT02466516 · Interventional trial

Safety, Tolerability, and Efficacy of GS-4997 Alone or in Combination With Simtuzumab (SIM) in Adults With Nonalcoholic Steatohepatitis (NASH) and Fibrosis Stages F2-F3

Overall registry status Completed

Phase 2

Conditions Non-Alcoholic Steatohepatitis (NASH)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov